NDC 51662-1565
LIDOCAINE HCI AND DEXTROSE
Lidocaine Hci And Dextrose
LIDOCAINE HCI AND DEXTROSE is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Dextrose Monohydrate; Lidocaine Hydrochloride Anhydrous.
| Product ID | 51662-1565_c75311e3-ca6f-40de-e053-2a95a90a1bda |
| NDC | 51662-1565 |
| Product Type | Human Prescription Drug |
| Proprietary Name | LIDOCAINE HCI AND DEXTROSE |
| Generic Name | Lidocaine Hci And Dextrose |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2021-07-17 |
| Marketing Category | NDA / |
| Application Number | NDA019830 |
| Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
| Substance Name | DEXTROSE MONOHYDRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS |
| Active Ingredient Strength | 5 g/100mL; g/100mL |
| Pharm Classes | Amide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |